These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1230049

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.
    Saha A, Chowdhury MI, Khanam F, Bhuiyan MS, Chowdhury F, Khan AI, Khan IA, Clemens J, Ali M, Cravioto A, Qadri F.
    Vaccine; 2011 Oct 26; 29(46):8285-92. PubMed ID: 21907255
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A duplex vibriocidal assay to simultaneously measure bactericidal antibody titers against Vibrio cholerae O1 Inaba and Ogawa serotypes.
    Yang JS, Choi S, Kim DD, Kang SS, Yun CH, Lee K, Han SH.
    J Microbiol Methods; 2009 Dec 26; 79(3):289-94. PubMed ID: 19796659
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M, Karlsson SL, Källgård S, Blomquist M, Ekman A, Nygren E, Holmgren J.
    Vaccine; 2011 Oct 06; 29(43):7505-13. PubMed ID: 21807059
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine (author's transl)].
    Gateff C, Dodin A, Wiart J.
    Ann Microbiol (Paris); 1975 Oct 06; 126(2):231-46. PubMed ID: 1098542
    [Abstract] [Full Text] [Related]

  • 13. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
    Kanungo S, Paisley A, Lopez AL, Bhattacharya M, Manna B, Kim DR, Han SH, Attridge S, Carbis R, Rao R, Holmgren J, Clemens JD, Sur D.
    Vaccine; 2009 Nov 16; 27(49):6887-93. PubMed ID: 19761838
    [Abstract] [Full Text] [Related]

  • 14. Cholera vaccine field trials in east Pakistan. 1. Reaction and antigenicity studies.
    Benenson AS, Joseph PR, Oseasohn RO.
    Bull World Health Organ; 1968 Nov 16; 38(3):347-57. PubMed ID: 5302328
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.
    Benenson AS, Saad A, Mosley WH.
    Bull World Health Organ; 1968 Nov 16; 38(2):277-85. PubMed ID: 5302303
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of potency of inactivated cholera vaccine by mouse protection assay & antibody induction method.
    Sood A, Sokhey J, Sharma SB, Gairola S, Singh S, Singh H.
    Indian J Med Res; 1994 Dec 16; 100():262-5. PubMed ID: 7829163
    [Abstract] [Full Text] [Related]

  • 19. Relationship of vibriocidal antibodies to history of cholera vaccination in Thai adult volunteers.
    Pitisuttithum P, Prayurahong B, Migasena S, Suntharasamai P.
    Southeast Asian J Trop Med Public Health; 1990 Jun 16; 21(2):219-24. PubMed ID: 2237590
    [Abstract] [Full Text] [Related]

  • 20. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM.
    Int Arch Allergy Appl Immunol; 1975 Jun 16; 49(4):434-52. PubMed ID: 808500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.